Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2007;100:520-526
Published online before print January 25, 2007, doi: 10.1161/01.RES.0000258855.60637.58
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
100/4/520    most recent
01.RES.0000258855.60637.58v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bogdarina, I.
Right arrow Articles by Clark, A. J.L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bogdarina, I.
Right arrow Articles by Clark, A. J.L.
Related Collections
Right arrow Nutrition
Right arrow ACE/Angiotension receptors
Right arrow Animal models of human disease
Right arrow Gene expression
Right arrow Hypertension - basic studies
Right arrowRelated Article
(Circulation Research. 2007;100:520.)
© 2007 American Heart Association, Inc.


Molecular Medicine

Epigenetic Modification of the Renin-Angiotensin System in the Fetal Programming of Hypertension

Irina Bogdarina, Simon Welham, Peter J. King, Shamus P. Burns, Adrian J.L. Clark

From the Centre for Endocrinology (I.B., S.W., P.J.K., A.J.L.C.), Barts & the London, Queen Mary University of London, UK; Department of Chemical and Biological Sciences (S.P.B.), University of Huddersfield, UK.

Correspondence to Professor A.J.L. Clark, Centre for Endocrinology, John Vane Science Centre, William Harvey Research Institute, Charterhouse Square, London EC1M 6BQ, UK. E-mail a.j.clark{at}qmul.ac.uk

Hypertension is a major risk factor for cardiovascular and cerebrovascular disease. Lifelong environmental factors (eg, salt intake, obesity, alcohol) and genetic factors clearly contribute to the development of hypertension, but it has also been established that stress in utero may program the later development of the disease. This phenomenon, known as fetal programming can be modeled in a range of experimental animal models. In maternal low protein diet rat models of programming, administration of angiotensin converting enzyme inhibitors or angiotensin receptor antagonists in early life can prevent development of hypertension, thus implicating the renin-angiotensin system in this process. Here we show that in this model, expression of the AT1b angiotensin receptor gene in the adrenal gland is upregulated by the first week of life resulting in increased receptor protein expression consistent with the increased adrenal angiotensin responsiveness observed by others. Furthermore, we show that the proximal promoter of the AT1b gene in the adrenal is significantly undermethylated, and that in vitro, AT1b gene expression is highly dependent on promoter methylation. These data suggest a link between fetal insults to epigenetic modification of genes and the resultant alteration of gene expression in adult life leading ultimately to the development of hypertension. It seems highly probable that similar influences may be involved in the development of human hypertension.


Key Words: hypertension • angiotensin receptors • fetal programming • DNA methylation


Related Article:

Developmental Programming Through Epigenetic Changes
Anne Monique Nuyt and Moshe Szyf
Circ. Res. 2007 100: 452-455. [Full Text] [PDF]



This article has been cited by other articles:


Home page
NEJMHome page
P. D. Gluckman, M. A. Hanson, C. Cooper, and K. L. Thornburg
Effect of In Utero and Early-Life Conditions on Adult Health and Disease
N. Engl. J. Med., July 3, 2008; 359(1): 61 - 73.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
P. Stenvinkel and T. J. Ekstrom
Epigenetics--a helpful tool to better understand processes in clinical nephrology?
Nephrol. Dial. Transplant., May 1, 2008; 23(5): 1493 - 1496.
[Full Text] [PDF]


Home page
Toxicol SciHome page
A. C. Aragon, P. G. Kopf, M. J. Campen, J. K. Huwe, and M. K. Walker
In Utero and Lactational 2,3,7,8-Tetrachlorodibenzo-p-dioxin Exposure: Effects on Fetal and Adult Cardiac Gene Expression and Adult Cardiac and Renal Morphology
Toxicol. Sci., February 1, 2008; 101(2): 321 - 330.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. M. Nuyt and M. Szyf
Developmental Programming Through Epigenetic Changes
Circ. Res., March 2, 2007; 100(4): 452 - 455.
[Full Text] [PDF]